BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 6979383)

  • 1. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased epidermal growth factor binding in cells growth arrested in G1 by nutrient deficiency.
    Robinson RA; Volkenant ME; Ryan RJ; Moses HL
    J Cell Physiol; 1981 Dec; 109(3):517-24. PubMed ID: 6459329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors, growth factor receptors, and cell cycle control mechanisms in chemically transformed cells.
    Moses HL; Robinson RA
    Fed Proc; 1982 Nov; 41(13):3008-11. PubMed ID: 6292004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organization and expression of endogenous virus-like (VL30) DNA sequences in nontransformed and chemically transformed mouse embryo cells in culture.
    Courtney MG; Schmidt LJ; Getz MJ
    Cancer Res; 1982 Feb; 42(2):569-76. PubMed ID: 6275981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
    Levine AE; McRae LJ; Brattain MG
    Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of epidermal growth factor receptor induction by retinoic acid in a chemically transformed rat liver cell line.
    Raymond VW; Grisham JW; Earp HS
    Cell Growth Differ; 1990 Sep; 1(9):393-9. PubMed ID: 2288880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
    Pietenpol JA; Howe PH; Cunningham MR; Leof EB
    J Cell Physiol; 1989 Dec; 141(3):453-60. PubMed ID: 2687295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of normal growth control and membrane antigen composition in malignant cells by N,N-dimethylformamide.
    Chakrabarty S; McRae LJ; Levine AE; Brattain MG
    Cancer Res; 1984 May; 44(5):2181-5. PubMed ID: 6608991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface features associated with differentiation-induction of methylcholanthrene-transformed AKR-2B fibroblasts by N,N-dimethylformamide.
    Marks ME; Ziober BL; Brattain MG
    Cancer Res; 1985 Mar; 45(3):1276-84. PubMed ID: 3855694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responsiveness of normal and simian virus 40-transformed BALB/c 3T3 cells to retinoic acid: rapid enhancement of epidermal growth factor receptor binding in a simian virus 40-3T3 variant.
    Chen JK; Li LW; Mioh H
    Cancer Res; 1987 Oct; 47(19):4995-9. PubMed ID: 3040236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding, internalization, and degradation of epidermal growth factor by balb 3T3 and BP3T3 cells: relationship to cell density and the stimulation of cell proliferation.
    Brown KD; Yeh YC; Holley RW
    J Cell Physiol; 1979 Aug; 100(2):227-38. PubMed ID: 315945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM; Levine AE; Hinshaw XH
    Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of fibronectin synthesis and fibronectin binding during transformation and differentiation of mouse AKR fibroblasts.
    Varani J; Chakrabarty S
    J Cell Physiol; 1990 Jun; 143(3):445-54. PubMed ID: 2141611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A.
    Serrero G; Lepak NM; Hayashi J; Eisinger DP
    Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.